Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: Clinical description of 16 cases

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 3, 2009, Pages 245-253

  Dufour, Jean François ^a   Pradat, Pierre ^b   Ruivard, Marc ^c   Hot, Arnaud ^d   Dumontet, Charles ^d   Broussolle, Christiane ^a   Trepo, Christian ^b   Sève, Pascal ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b HÔTEL DIEU   (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Autoimmune hemolytic anemia; Hepatitis C virus; Immune thrombocytopenic purpura

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE; RIBAVIRIN; RITUXIMAB; ANTIVIRUS AGENT; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE THROMBOCYTOPENIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPENIA; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SPLENECTOMY; TREATMENT FAILURE; TREATMENT RESPONSE; COMPLICATION; HEPATITIS C, CHRONIC; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIROLOGY; VIRUS LOAD;

AGED; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIVIRAL AGENTS; FEMALE; GLUCOCORTICOIDS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VIRAL LOAD;

EID: 62349095950     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283249908     Document Type: Article

References (43)

1. Consensus Conference. Treatment of hepatitis C. Gastroenterol Clin Biol 2002; 26 (Spec No 2):B303-B320.
2. Agnello V, De Rosa FG. Extrahepatic disease manifestations of HCV infection: some current issues. J Hepatol 2004; 40:341-352.
3. Cacoub P, Fabiani FL, Musset L, Perrin M, Frangeul L, Leger JM, et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994; 96:124-132.
4. Silva M, Li X, Cheinquer H, Kolodny H, Radick J, La Rue S, Hill M. HCV-associated idiopathic thrombocytopenic purpura (ITP). Gastroenterology 1992; 102:A889
5. Pawlotsky JM, Bouvier M, Fromont P, Deforges L, Duval J, Dhumeaux D, Bierling P. Hepatitis C virus infection and autoimmune thrombocytopenic purpura. J Hepatol 1995; 23:635-639.
6. Pivetti S, Novarino A, Merico F, Bertero MT, Brunette MR, Bonino F, Caligaris-Cappio F. High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with tymphoproliferative and connective tissue disorders. Br J Haematol 1996; 95:204-211.
7. Linares M, Pastor E, Hernandez F, Montagud M, Blanquer A. Autoimmune thrombocytopenia and hepatitis C virus infection. Am J Hematol 1996; 53:284.
8. Rajan SK, Espina BM, Liebman HA. Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura. Br J Haematol 2005; 129:818-824.
9. Sakuraya M, Murakami H, Uchiumi H, Hatsumi N, Akiba T, Yokohama A, et al. Steroid-refractory chronic idiopathic thrombocytopenic purpura associated with hepatitis C virus infection. Eur J Haematol 2002; 68:49-53.
10. Garcia-Suarez J, Burgaleta C, Hernanz N, Albarran F, Tobaruela P, Alvarez-Mon M. HCV-associated thrombocytopenia: clinical characteristics and platelet response after recombinant alpha2b-interferon therapy. Br J Haematol 2000; 110:98-103.
11. Liebman HA, Stasi R. Secondary immune thrombocytopenic purpura. Curr Opin Hematol 2007; 14:557-573.
12. Pockros PJ, Duchini A, McMillan R, Nyberg LM, McHutchison J, Viernes E. Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. Am J Gastroenterol 2002; 97:2040-2045.
13. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88:3-40.
14. Tchelepi H, Ralls PW, Radin R, Grant E. Sonography of diffuse liver disease. J Ultrasound Med 2002; 21:1023-1032. Quiz 1033-1034.
15. Neylon AJ, Saunders PW, Howard MR, Proctor SJ, Taylor PR. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol 2003; 122:966-974.
16. Ramos-Casals M, Garcia-Carrasco M, Lopez-Medrano F, Trejo O, Forns X, Lopez-Guillermo A, et al. Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases. Medicine (Baltimore) 2003; 82:87-96.
17. Elhajj II, Sharara Al, Taher AT. Chronic hepatitis C associated with Coombs-positive hemolytic anemia. Hematol J 2004; 5:364-366.
18. Etienne A, Gayet S, Vidal F, Poullin P, Brunei C, Harlé JR, Kaplanski G. Severe hemolytic anemia due to cold agglutinin complicating untreated chronic hepatitis C: efficacy and safety of anti-CD20 (rituximab) treatment. Am J Hematol 2004; 75:243-245.
19. Grimaldi D, Limal N, Noizat-Pirenne F, Janvier D, Godeau B, Michel M. IgA-mediated auto-immune haemolytic anaemia revealing a hepatitis C virus infection. Rev Med Interne 2008; 29:135-138.
20. Moccia F, Tognoni E, Boccaccio P. Autoimmune hemolytic anemia in chronic hepatitis C virus infection: an unusual extrahepatic autoimmune manifestation. Ann Ital Med Int 2001; 16:256-259.
21. Ohsawa I, Uehara Y, Hashimoto S, Endo M, Fujita T, Ohi H. Autoimmune hemolytic anemia occurred prior to evident nephropathy in a patient with chronic hepatitis C virus infection: case report. BMC Nephrol 2003; 4:7.
22. D'Alteroche L, Assor P, Lefrou L, Senecal D, Gaudy C, Bacq Y. Severe autoimmune neutropenia and thrombopenia associated with chronic C hepatitis: effect of antiviral therapy. Gastroenterol Clin Biol 2005; 29:297-299.
23. McMurray RW, Elbourne K. Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 1997; 2:689-701.
24. Adinolfi LE, Giordano MG, Andreana A, Tripodi MF, Utili R, Cesaro G, et al. Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. Br J Haematol 2001; 113:590-595.
25. Hamaia S, Li C, Allain JP. The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines. Blood 2001; 98:2293-2300.
26. Bordin G, Ballare M, Zigrossi P, Bertoncelli MC, Paccagnino L, Baroli A, et al. A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: a direct role of HCV in bone marrow exhaustion? Clin Exp Rheumatol 1995; 13 (Suppl 13):S39-S43.
27. Kayali Z, Buckwold VE, Zimmerman B, Schmidt WN. Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology 2002; 36:978-985.
28. Prelog M. Aging of the immune system: a risk factor for autoimmunity? Autoimmun Rev 2006; 5:136-139.
29. Rosa D, Saletti G, De Gregorio E, Zorat F, Comar C, D'Oro U, et al. Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci U S A 2005; 102:18544-18549.
30. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002; 346:995-1008.
31. Hernandez F, Blanquer A, Linares M, Lopez A, Tarin F, Cervero A. Autoimmune thrombocytopenia associated with hepatitis C virus infection. Acta Haematol 1998; 99:217-220.
32. Zhang L, Li H, Zhao H, Ji L, Yang R. Hepatitis C virus-related adult chronic idiopathic thrombocytopenic purpura: experience from a single Chinese center. Eur J Haematol 2003; 70:196-197.
33. lsenberg DA. B cell targeted therapies in autoimmune diseases. J Rheumatol Suppl 2006; 77:24-28.
34. Cacoub P, Delluc A, Saadoun D, Landau DA, Sene D. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand? Ann Rheum Dis 2008; 67:283-287.
35. Arnold DM, Derrtali F, Crowther MA, Ralph MM, Cook RJ, Sigouin C, et al. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med 2007; 146:25-33.
36. Weitz IC. Treatment of immune thrombocytopenia associated with interferon therapy of hepatitis C with the anti-CD20 monoclonal antibody, rituximab. Am J Hematol 2005; 78:138-141.
37. Ennishi D, Terui Y, Yokoyama M, Mishima Y, Takahashi S, Takeuchi K, et al. Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV-infected CD20-positive B-cell lymphoma undergoing rituximab combination chemotherapy. Am J Hematol 2007; 83:59-62.
38. Rajan S, Liebman HA. Treatment of hepatitis C related thrombocytopenia with interferon alpha. Am J Hematol 2001; 68:202-209.
39. Peck-Radosavljevic M, Wichlas M, Homoncik-Kraml M, Homoncik-Kraml M, Kreil A, Hofer H, et al. Rapid suppression of hematopoiesis by standard or pegylated interferon-alpha. Gastroenterology 2002; 123:141-151.
40. Godeau B, Provan D, Bussel J. Immune thrombocytopenic purpura in adults. Curr Opin Hematol 2007; 14:535-556.
41. Bussel JB, Cheng G, Saleh MN, Psaila B, Kovaleva L, Meddeb B, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 2007; 387:2237-2247.
42. Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gemsheimer TB, Senecal FM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet 2008; 371:395-403.
43. McHutchison JG, Dusheiko G, Shiftman ML, Rodriguez-Torres M, Sigal S, Bourliere M, et al. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N Engl J Med 2007; 357:2227-2236.